Pharm-Olam International (POI) has signed a multi-year, multi-million dollar contract with Datatrak for the cloud-based unified clinical research solution, Datatrak One.
The solution deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in many languages across the world.
POI also uses Datatrak solutions such as uDesign, uIRT, uEDC and uTrain.
Pharm-Olam COO John Hovre said,"The expansion of our partnership positions Pharm-Olam to offer sponsors more dynamic, integrated data solutions for full service and functional outsourcing."
Datatrak Chairman of the Board and CEO Laurence P. Birch said, "POI is a long-term client committed to another five years. This partnership is a testament to the superiority of DATATRAK's technology and services delivery. We look forward to continuing to deliver the most user-friendly, powerful clinical research platform in support of Pharm-Olam's delivery of clinical trials."
